| XDR-TB | 4/12 (33) |
| Resistance to streptomycin | 10/12 (83) |
| Resistance to ethambutol | 9/12 (75) |
| Resistance to pyrazinamide | 9/12 (75) |
| Resistance to fluoroquinolones | 7/12 (58) |
| Resistance to amikacin | 3/12 (25) |
| Resistance to kanamycin | 6/11 (54) |
| Resistance to capreomycin | 3/11 (27) |
| Previous exposure to anti-TB therapy >30 days | 9/12 (75) |
| Median (IQR) number of times treated with anti-TB drugs >1 month | 2 (0.5–8) |
Data are presented as n/N (%), unless otherwise stated. IQR: interquartile range.